White House Threatens Innovation with Drug Price Indexing
Timmons: “The White House has chosen to dangle an axe above these manufacturers’ heads”
Washington, D.C. – The National Association of Manufacturers launched a new seven-figure television and digital ad campaign aimed at potential rules to address drug pricing through International Price Indexing.
“As the nation continues to battle the COVID-19 pandemic, we should not be enacting policies that could potentially stifle pharmaceutical innovation. Price-setting schemes manipulated by foreign governments have no place in our economy. They could impact our ability to develop cures for future pandemics, cancer or Alzheimer’s. So we’re unsure why the White House has chosen to dangle an axe above these manufacturers’ heads by threatening this policy,” said NAM President and CEO Jay Timmons.
“Manufacturers are constantly working to lower costs for top-quality medicines and therapies, and we know that importing policies that have failed elsewhere won’t achieve that goal.”
To view the ad, click here.
The National Association of Manufacturers is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs more than 11.7 million men and women, contributes $2.37 trillion to the U.S. economy annually and has the largest economic multiplier of any major sector and accounts for 63% of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States. For more information about the NAM or to follow us on Twitter and Facebook, please visit www.nam.org